Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CANF | TAK | ZTS | GRFS | NBIX |
| Company | Can-Fite Biopharma Ltd ADR | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Grifols S.A. ADR | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.9400 | 13.15 | 150.97 | 6.33 | 139.37 |
| High | 1.9703 | 13.19 | 153.59 | 6.37 | 139.37 |
| Low | 1.9100 | 13.05 | 150.04 | 6.12 | 136.06 |
| Last | 1.9200 | 13.07 | 153.36 | 6.27 | 137.76 |
| Change | -0.0200 | -0.16 | +2.48 | -0.12 | -1.21 |
| % Change | -1.03% | -1.21% | +1.64% | -1.88% | -0.87% |
| Volume | 12,300 | 1,697,100 | 4,567,100 | 1,012,200 | 735,700 |
| 20-Day Average Volume | 18,300 | 1,762,665 | 4,188,745 | 1,361,055 | 792,185 |
| Previous Close | 1.9400 | 13.23 | 150.88 | 6.39 | 138.97 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.1502 | 13.43 | 157.90 | 6.69 | 136.56 |
| 20-Day Raw Stochastic | 1.25% | 2.20% | 32.50% | 12.20% | 51.31% |
| 20-Day Relative Strength | 38.64% | 33.91% | 37.68% | 42.51% | 52.08% |
| Weighted Alpha | -10.05 | -21.99 | -18.25 | -4.85 | +38.02 |
| Today's Opinion | 40% Sell | 100% Sell | 88% Sell | 100% Sell | 96% Buy |
| Previous Opinion | 40% Sell | 100% Sell | 88% Sell | 100% Sell | 96% Buy |
| Last Month's Opinion | 8% Sell | 56% Sell | 40% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.54% since 04/18/24 | -0.68% since 04/18/24 | +0.16% since 04/18/24 | -4.13% since 04/18/24 | +3.94% since 04/18/24 |
| Low | 1.9100 on 04/25/24 | 13.05 on 04/25/24 | 144.80 on 04/22/24 | 6.12 on 04/25/24 | 130.13 on 04/19/24 |
| High | 2.0700 on 04/19/24 | 13.41 on 04/23/24 | 153.59 on 04/25/24 | 6.66 on 04/23/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -12.33% since 03/25/24 | -7.63% since 03/25/24 | -8.61% since 03/25/24 | -1.42% since 03/25/24 | -1.78% since 03/25/24 |
| Low | 1.9100 on 04/25/24 | 13.05 on 04/25/24 | 144.80 on 04/22/24 | 6.12 on 04/25/24 | 130.13 on 04/19/24 |
| High | 2.7100 on 04/01/24 | 14.45 on 03/26/24 | 171.14 on 03/28/24 | 7.35 on 04/09/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | -1.54% since 01/25/24 | -10.66% since 01/25/24 | -18.13% since 01/25/24 | -17.82% since 01/25/24 | -2.30% since 01/25/24 |
| Low | 1.9100 on 04/25/24 | 13.05 on 04/25/24 | 144.80 on 04/22/24 | 5.30 on 03/06/24 | 128.00 on 02/07/24 |
| High | 2.7100 on 04/01/24 | 14.88 on 02/27/24 | 200.53 on 02/29/24 | 9.37 on 02/28/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +0.42% since 10/25/23 | -9.86% since 10/25/23 | -6.30% since 10/25/23 | -19.20% since 10/25/23 | +27.28% since 10/25/23 |
| Low | 1.8100 on 10/27/23 | 13.05 on 04/25/24 | 144.80 on 04/22/24 | 5.30 on 03/06/24 | 103.63 on 11/10/23 |
| High | 2.8000 on 11/21/23 | 15.07 on 01/12/24 | 201.92 on 12/14/23 | 12.15 on 12/29/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,868 | 41,870,544 | 69,006,328 | 4,393,509 | 13,828,489 |
| Shares Outstanding, K | 3,540 | 3,164,818 | 457,359 | 687,560 | 99,507 |
| Annual Sales | 740,000 | 29,803,340,000 | 8,544,000,000 | 7,134,500,000 | 1,887,100,000 |
| Annual Net Income | -7,630,000 | 2,345,930,000 | 2,344,000,000 | 131,340,000 | 249,700,000 |
| Last Quarter Sales | 160,000 | 7,556,070,000 | 2,213,000,000 | 2,025,030,000 | 515,200,000 |
| Last Quarter Net Income | -1,650,000 | 718,900,000 | 525,000,000 | 125,920,000 | 147,700,000 |
| 60-Month Beta | 1.53 | 0.53 | 0.85 | 0.56 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 03/28/24 | 0.51 on 02/01/24 | 1.24 on 02/13/24 | 0.09 on 07/27/23 | 1.44 on 02/07/24 |
| Latest Earnings Date | 06/06/24 | 05/09/24 | 05/02/24 | 03/05/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.261 on 09/28/23 | 0.432 on 04/18/24 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 09/28/23 | 04/18/24 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.86 | 28.11 | 0.00 | 57.89 |